Horizon Discovery

Horizon Discovery is a revenue-generating life science group supplying research tools to organizations engaged in translational genomics research and the development of personalized medicines. Horizon serves various organizations including major pharmaceutical, biotechnology, and diagnostic companies as well as leading academic research centers. The Group core capabilities are built around its proprietary translational genomics platform, a high-precision and flexible suite of gene editing tools able to alter almost any endogenous gene sequence of human or mammalian cell lines. Horizon offers a portfolio of products, almost all of which are based on the application of gene editing to generate cell lines that accurately model the disease-causing mutations found in genetically based diseases. These ‘patients-in-a-test-tube’ are being used by customers to identify the effect of individual or compound genetic mutations on drug activity, patient responsiveness, and resistance, which may lead to the successful prediction of which patient sub-groups will respond to currently available and future drug treatments. In addition, it provides custom cell line and in vivo model generation services for research and bioproduction applications, quantitative molecular reference standards, in vivo disease models, and contract research and custom screening services.

Company Growth (employees)
Type
Public
HQ
Waterbeach, GB
Founded
2005
Size (employees)
234 (est)
Horizon Discovery was founded in 2005 and is headquartered in Waterbeach, GB

Key People/Management at Horizon Discovery

Darrin Disley

Darrin Disley

Chief Executive Officer
Richard Vellacott

Richard Vellacott

Chief Financial Officer & Deputy Chief Executive Officer
Terry Pizzie

Terry Pizzie

Head of Commercial Operations
Heather Hayes

Heather Hayes

Head of Human Resources
Jurgen Harter

Jurgen Harter

Global Head of IT & Informatics
Jon Moore

Jon Moore

Chief Scientific Officer, Head of Translational Science
Tilmann Buerckstuemmer

Tilmann Buerckstuemmer

Global Head of Innovation

Horizon Discovery Office Locations

Horizon Discovery has offices in Waterbeach, Cambridge, Wien, St. Louis and in 1 other location
Waterbeach, GB (HQ)
Cambridge Research Park Beach Dr
Wien, AT
3 Campus-Vienna-Biocenter

Horizon Discovery Financials and Metrics

Horizon Discovery Financials

Horizon Discovery's revenue was reported to be £24.1 m in FY, 2016 which is a 19% increase from the previous period.
GBP

Revenue (FY, 2016)

24.1 m

Gross profit (FY, 2016)

13.1 m

Gross profit margin (FY, 2016), %

54%

Net income (FY, 2016)

(11.4 m)

EBITDA (FY, 2016)

(8.4 m)

EBIT (FY, 2016)

(12.4 m)

Market capitalization (31-Oct-2017)

246 m

Closing share price (31-Oct-2017)

2.5

Cash (31-Dec-2016)

6.1 m
Horizon Discovery's current market capitalization is £246 m.
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

6.6 m11.9 m20.2 m24.1 m

Revenue growth, %

79%69%

Cost of goods sold

3.2 m5.4 m10.2 m11 m

Gross profit

3.4 m6.6 m10 m13.1 m
GBPFY, 2013FY, 2014FY, 2015FY, 2016

Cash

4.2 m18.5 m25.1 m6.1 m

Accounts Receivable

1.4 m3.9 m7 m10.2 m

Inventories

453 k1.3 m1.8 m2 m

Current Assets

6.7 m25.8 m36.5 m20.6 m
    GBPFY, 2013FY, 2014FY, 2015FY, 2016

    Net Income

    (3 m)(5.9 m)(9.9 m)(11.4 m)

    Cash From Operating Activities

    (2.2 m)(6.5 m)(11 m)(8.2 m)

    Cash From Financing Activities

    3.7 m37.6 m24.3 m141 k

    Net Change in Cash

    496.6 k14.3 m6.6 m(19.4 m)
      Y, 2016

      Financial Leverage

      1.1 x
      Show all financial metrics

      Horizon Discovery Market Value History

      Horizon Discovery's Web-traffic and Trends

      Horizon Discovery Online and Social Media Presence

      Horizon Discovery Company Life and Culture

      You may also be interested in